The use of racial categories in genomic biology and biomedicine has become increasingly common, as seen in racial identification of DNA samples and race-specific pharmaceuticals such as BiDil. Against the historical backdrop of the American eugenics movement, such classification should be viewed with caution. While racial health disparities are an important challenge for public health, it is important that interventions not reinforce the inequalities they seek to address. The ACLU is currently monitoring these developments.
LEARN MORE Racial Justice >>